Stability Data Does Not Support Expiry Date.
Stability Data Does Not Support Expiry Date.
Consumers and healthcare providers should stop using this product immediately. Contact HTO Nevada Inc. dba Kirkman or your healthcare provider for guidance. Notification method: E-Mail
Get instant alerts for HTO Nevada Inc. dba Kirkman recalls
Be the first to know. Free instant alerts to your inbox.
MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.. Reason: Stability Data Does Not Support Expiry Date.. Classification: Class II. Quantity: 243 bottles. Distribution: Nationwide within the U.S
Get instant alerts for recalls that affect you. Free forever.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Stability Data Does Not Support Expiry Date.
Stability Data Does Not Support Expiry Date.
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Defective container; inadequately sealed blister packaging.
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution